Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00666003 · ClinicalTrials.gov registry record
Hemodynamic Assessment APCO Monitor vs Crit Line for Renal Replacement Rx
A clinical trial, sponsored by Baystate Medical Center.
- Completed
- Registry status
- 26
- Enrollment target
NCT00666003: Completed study, sponsored by Baystate Medical Center.
NCT00666003 is a clinical trial that has completed, run by Baystate Medical Center. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00666003 has completed, sponsored by Baystate Medical Center.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
Fluid and volume management are a challenging part of critical care and the difficulties increase in the face of renal failure. Utilizing the Crit-Line to monitor blood volume changes in conjunction with arterial pressure cardiac output monitoring may lead to better understanding of the impact fluid removal during dialysis has on hemodynamics.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2008-04 |
| Est. Completion | 2009-11 |
What the finished NCT00666003 record still lists
NCT00666003 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00666003 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00666003 about?
NCT00666003 is a clinical study titled "Hemodynamic Assessment APCO Monitor vs Crit Line for Renal Replacement Rx". Fluid and volume management are a challenging part of critical care and the difficulties increase in the face of renal failure. Utilizing the Crit-Line to monitor blood volume changes in conjunction with arterial pressure cardiac output monitoring may lead to better understanding of the impact fluid...
What is the current status of trial NCT00666003?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2008-04. Estimated completion is 2009-11.
Who is sponsoring clinical trial NCT00666003?
This trial is sponsored by Baystate Medical Center, which has 36 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia